Nolla Health

Nolla Health, based in New York, is a pioneering company specializing in dermatological care through the integration of advanced AI technology and the expertise of licensed medical professionals. Nolla Health provides innovative dermatological solutions, primarily focusing on skin treatment and cancer assessments. Founded in 2024, the company has successfully completed one deal, raising USD 4. 5 mn in Seed funding led by General Catalyst Partners on September 18, 2025.

The firm was established by individuals whose specific backgrounds are not disclosed. Nolla specializes in providing innovative dermatological care solutions that leverage advanced artificial intelligence (AI) technology alongside the expertise of licensed medical professionals. Their primary offerings include AI-powered skin treatment for acne and comprehensive skin cancer assessments through mole scans. Users can utilize their mobile application to scan their skin and receive personalized treatment plans based on AI analyses, which are subsequently reviewed and validated by clinicians.

This product is designed for individuals seeking accessible, fast, and accurate skin care solutions, addressing conditions such as acne and potential skin cancer. Nolla's services are available directly to consumers across various geographical markets, including the United States and parts of Europe, aiming to enhance skin health and streamline access to dermatological care. Nolla operates on a direct-to-consumer revenue model, allowing clients to access their skin care services without the need for insurance or traditional healthcare barriers. Users can download the Nolla app and engage in a simple guided scan process that results in a personalized care plan created by licensed doctors.

The business model involves a fixed pricing structure for individual services, including acne treatment and mole scan services, ensuring transparency and convenience for customers. This straightforward approach eliminates the complexities typically associated with healthcare transactions, such as referrals and co-pays. The firm focuses on providing high-quality dermatological care through its technology-driven platform, contributing to its revenue generation by catering to a growing segment of consumers seeking efficient and effective skin health solutions. Nolla Health aims to utilize the recently raised USD 4.

5 mn in Seed funding to enhance its presence in the U. S. market, develop new skin care tools, and improve its AI system. The company is focused on launching upcoming products designed to expand its service offerings while also targeting geographic expansion into additional regions in Europe.

The company’s strategic initiatives are set to enhance their capabilities and reach by the end of 2025.